National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Thalassemia Major, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Recruiting | Phase 2 | 2025-05-30 | NCT06490627 | |
| Long Term Beta Thalassemia Treatment: Findings From The Extension Period | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, thalassemia | Active, not recruiting | Phase 2 | 2025-05-30 | NCT06490601 | |
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases | Axial Spondyloarthritis, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, dermatomyositis, immune system disorder, juvenile idiopathic arthritis, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease, polymyositis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, systemic lupus erythematosus, systemic sclerosis, vertebral column disorder | Enrolling by invitation | Phase 1 / Phase 2 | 2025-03-21 | NCT06888973 | |
| The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia. | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, alopecia, androgenetic alopecia, disorder of pilosebaceous unit, hypotrichosis, skin disorder | Enrolling by invitation | Phase 1 / Phase 2 | 2025-01-08 | NCT06764329 |